Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Confidentiality clauses: I may be bursting bubbles, but....

I think the settlement will be sufficient enough to allow our S/P to be $1.50 to $4.00 per share. (not considering any other factors such as investor buying momenteum)I base this on what Eric Swartz said at the Share Holder meeting. Since he is in a better position than I to insider dealings, I chose to consider what he says.

JMO

Share
New Message
Please login to post a reply